These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 11722113)
1. Red blood cells: an analysis of risk versus benefit. Ellison N Ann Thorac Surg; 2001 Nov; 72(5):S1806-7. PubMed ID: 11722113 [TBL] [Abstract][Full Text] [Related]
3. Blood doping in athletes--detection of allogeneic blood transfusions by flow cytofluorometry. Arndt PA; Kumpel BM Am J Hematol; 2008 Aug; 83(8):657-67. PubMed ID: 18508326 [TBL] [Abstract][Full Text] [Related]
4. Rapid destruction of apparently compatible red cells. STEWART JW; MOLLISON PL Br Med J; 1959 May; 1(5132):1274-5. PubMed ID: 13651707 [No Abstract] [Full Text] [Related]
5. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery. Guzzetta NA Paediatr Anaesth; 2011 May; 21(5):504-11. PubMed ID: 21114707 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Madjdpour C; Spahn DR Br J Anaesth; 2005 Jul; 95(1):33-42. PubMed ID: 15486006 [TBL] [Abstract][Full Text] [Related]
7. Blood usage in an Australian intensive care unit: have we met best practice goals? Farrar D; Robertson MS; Hogan CJ; Roy S; Boyce CA; Howe BD; Presneill JJ; Cade JF Anaesth Intensive Care; 2004 Dec; 32(6):775-80. PubMed ID: 15648987 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunisation: still a major complication of blood transfusion. Pereira A Br J Haematol; 2018 Jun; 181(5):575-576. PubMed ID: 29676454 [No Abstract] [Full Text] [Related]
9. Letter: Red blood cell transfusions. Hrubisko M Transfusion; 1975; 15(3):302-3. PubMed ID: 1129840 [No Abstract] [Full Text] [Related]
12. Use of isotope-labelled red cells to demonstrate incompatibility in vivo. MOLLISON PL; CUTBUSH M Lancet; 1955 Jun; 268(6878):1290-5. PubMed ID: 14382582 [No Abstract] [Full Text] [Related]
13. Avoiding overtransfusion: an update on risks and latest indications. Brown MR; Jennings PR JAAPA; 2012 Aug; 25(8):42-5. PubMed ID: 22928276 [No Abstract] [Full Text] [Related]
14. Evidence and triggers for the transfusion of blood and blood products. Shah A; Stanworth SJ; McKechnie S Anaesthesia; 2015 Jan; 70 Suppl 1():10-9, e3-5. PubMed ID: 25440390 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035 [TBL] [Abstract][Full Text] [Related]
16. Gaps in Research on Adverse Events to Transfusion in Pediatrics. Jackups R; Savage W Transfus Med Rev; 2016 Oct; 30(4):209-12. PubMed ID: 27488141 [TBL] [Abstract][Full Text] [Related]
17. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]